DTC Skin Care Clinics® Early detection of skin cancer is essential in Primary Care Physician (PCP) clinics to identify malignant lesions before they progress. DTC Skin Cancer Care Clinics® utilize AI-powered tools like DermaSensor, a non-invasive, FDA-registered device that enables rapid, point-of-care skin lesion analysis.

This handheld technology delivers objective results in seconds NOT days, helping PCPs detect risk early and decide when further dermatologic evaluation is needed. Seamlessly integrating into the clinical workflow, it supports earlier diagnosis, improves patient outcomes, and reduces unnecessary referrals—bringing dermatologic insight directly into primary care.

Clinical Considerations:

While there's no universal national mandate, annual or as-needed screenings is widely supported for high-risk patients, and provider discretion is key for broader populations. 

Before...

Your skin becomes a battle of life and death,

there’s hope for early detection at DTC.

DermaSensor™ – The Future of Skin Cancer Detection at the Point of Care

At Diabetes Testing Centers™ (DTC), we Go Beyond Diabetes Care to help medical providers identify health risks early—before they become life-altering. DermaSensor™ aligns with our mission by delivering a fast, non-invasive, and reimbursable way to screen for skin cancer in any clinical setting.

Why Skin Cancer Screening Matters for Every Provider

Skin cancer is the most common cancer in the United States, with over 5 million cases diagnosed annually. Early detection is critical—and often life-saving. Yet, access to dermatology remains limited, and many suspicious lesions go unexamined.

Primary care physicians, OB/GYNs, concierge providers, and urgent care centers are in a unique position to identify high-risk skin lesions during routine exams—but often lack the tools or training to do so confidently. DermaSensor™ fills that gap.

What Is DermaSensor™?

DermaSensor™ is the first FDA-cleared, non-invasive skin cancer detection device designed specifically for frontline healthcare providers. Using advanced Elastic Scattering Spectroscopy (ESS) and proprietary machine learning algorithms, the device evaluates cellular structure and generates a risk classification in under 30 seconds.

No Scalpels. No Pathology. No Result-Related Anxieties.

Ideal for These Clinical Settings:

• Primary Care & Family Medicine

• OB/GYN Practices (skin checks during annual exams)

• Concierge & Direct Primary Care Clinics

• Medical Aesthetics & Med Spas (pre-procedure risk evaluation)

• Health Systems & ACOs (value-based care + preventive metrics)

• Urgent Care & Walk-In Clinics (spot-checks for acute concerns)

Who Should Be Screened More Frequently?

• Patients with the following should be screened at least annually, possibly more often:

• Personal or family history of melanoma, BCC, or SCC

• History of indoor tanning or significant sunburns

• Immunosuppressed individuals (e.g., transplant recipients)

• Fair skin, red/blonde hair, blue/green eyes

• Large number of moles or atypical nevi

• History of radiation or chemical exposure

Workflow Efficiency & Staff-Friendly Design

DermaSensor™ is engineered for simplicity and speed:

• Test takes less than 1 minute from start to finish

• No additional staff required—can be performed by the provider or trained MA

• Results available in real-time during the patient visit

• Reduces administrative time by eliminating biopsy referrals

• Includes onboarding, protocol training, and billing guidance

Differentiate Your Clinic Without Adding Costly Complexity

You don’t need to become a dermatologist to catch skin cancer early. DermaSensor™ allows your clinic to:

• Expand your clinical value proposition

• Offer preventive cancer screening in-house

• Retain patients who might otherwise be referred out

• Enhance your role in total patient care and risk stratification

Referral & Patient Retention Opportunities

• Patients feel safer and more confident when skin checks are part of their routine visit

• Providers can catch lesions early—before they require surgery or lead to metastatic disease

• Clinics offering DermaSensor™ become known as comprehensive, proactive, and tech-forward in their communities

Why DTC Recommends DermaSensor™

At DTC, we believe that every primary care and frontline provider should have access to the tools that make life-saving screenings simple, fast, and financially viable.

DermaSensor™ represents the future of preventive medicine—portable, intelligent, reimbursable, and patient-friendly.

AI Devices Elevate PCP Clinics

Ready to Lean More

We can help your clinic:

• Schedule a virtual product demo

• Receive workflow integration support

• Access provider marketing kits and patient education tools

• Join a priority referral network with other clinics using DermaSensor™

Contact DTC today to see how you can bring skin cancer detection into your exam room—without disrupting your schedule, staff, or bottom line.

Detect Skin Cancer—In Seconds, Not Weeks or Months.

No Cutting. No Waiting. No Kidding.